Behavioral effects of naloxone infusion in obsessive-compulsive disorder.
Keuler
D J
DJ
Laboratory of Clinical Science, National Institute of Mental Health, Bethesda, Maryland, USA.
Altemus
M
M
Michelson
D
D
Greenberg
B
B
Murphy
D L
DL
D000328:Adult; D001143:Arousal / Q000187:drug effects / Q000502:physiology*; D004311:Double-Blind Method; D005260:Female; D006801:Humans; D007262:Infusions, Intravenous; D008297:Male; D009270:Naloxone; D009292:Narcotic Antagonists; D009771:Obsessive-Compulsive Disorder / Q000175:diagnosis / Q000503:physiopathology* / Q000523:psychology; D018847:Opioid Peptides / Q000502:physiology; D010555:Personality Inventory
D009292:Narcotic Antagonists; D018847:Opioid Peptides; D009270:Naloxone